Pub Date : 2026-06-01Epub Date: 2026-02-07DOI: 10.1016/j.jad.2026.121336
Shouying Li , Jiaxin Feng , Shilin Zhang
Objective
To describe and compare the reporting patterns and signal strengths of male sexual dysfunction associated with six commonly prescribed SSRIs in the FDA Adverse Event Reporting System.
Methods
Adverse event data for six representative SSRIs, fluoxetine, paroxetine, sertraline, fluvoxamine, citalopram, and escitalopram, were retrieved from the FAERS database, spanning from the first quarter of 2004 to the first quarter of 2025. Disproportionality analysis was conducted using both the reporting odds ratio (ROR) and proportional reporting ratio (PRR) to identify potential signals of adverse drug events associated with these medications.
Results
We analyzed 6,631,746 adverse drug event reports associated with SSRIs and detected significant disproportionality signals indicative of male sexual dysfunction in patients with depression. Across all SSRIs, erectile dysfunction was the most commonly reported adverse event [fluoxetine (ROR: 4.97, 95%CI: 4.25–5.82), paroxetine (ROR: 3.99, 95%CI: 3.53–4.5), sertraline (ROR: 6.11, 95%CI: 5.53–6.75), fluvoxamine (ROR: 1.08, 95%CI: 0.35–3.36), citalopram (ROR: 7.7, 95%CI: 6.81–8.69), and escitalopram (ROR: 7.93, 95%CI: 6.99–8.99)], followed by sexual dysfunction [fluoxetine (ROR: 11.94, 95%CI: 10.01–14.23), paroxetine (ROR: 11.39, 95%CI: 10.05–12.91), sertraline (ROR: 13.34, 95%CI: 11.86–15.01), fluvoxamine (ROR: 9.64, 95%CI: 5.01–18.56), citalopram (ROR: 15.09, 95%CI: 12.98–17.54), and escitalopram (ROR: 16.42, 95%CI: 14.11–19.12)].
Conclusion
This FAERS analysis detected significant disproportionality signals for male sexual dysfunction across SSRIs. Signal variation reflects reporting differences, not comparative risk, due to database limitations. These findings highlight the need for clinical vigilance and further investigation.
{"title":"Male sexual dysfunction associated with selective serotonin reuptake inhibitors (SSRIs): A pharmacovigilance disproportionality analysis of FAERS data","authors":"Shouying Li , Jiaxin Feng , Shilin Zhang","doi":"10.1016/j.jad.2026.121336","DOIUrl":"10.1016/j.jad.2026.121336","url":null,"abstract":"<div><h3>Objective</h3><div>To describe and compare the reporting patterns and signal strengths of male sexual dysfunction associated with six commonly prescribed SSRIs in the FDA Adverse Event Reporting System.</div></div><div><h3>Methods</h3><div>Adverse event data for six representative SSRIs, fluoxetine, paroxetine, sertraline, fluvoxamine, citalopram, and escitalopram, were retrieved from the FAERS database, spanning from the first quarter of 2004 to the first quarter of 2025. Disproportionality analysis was conducted using both the reporting odds ratio (ROR) and proportional reporting ratio (PRR) to identify potential signals of adverse drug events associated with these medications.</div></div><div><h3>Results</h3><div>We analyzed 6,631,746 adverse drug event reports associated with SSRIs and detected significant disproportionality signals indicative of male sexual dysfunction in patients with depression. Across all SSRIs, erectile dysfunction was the most commonly reported adverse event [fluoxetine (ROR: 4.97, 95%CI: 4.25–5.82), paroxetine (ROR: 3.99, 95%CI: 3.53–4.5), sertraline (ROR: 6.11, 95%CI: 5.53–6.75), fluvoxamine (ROR: 1.08, 95%CI: 0.35–3.36), citalopram (ROR: 7.7, 95%CI: 6.81–8.69), and escitalopram (ROR: 7.93, 95%CI: 6.99–8.99)], followed by sexual dysfunction [fluoxetine (ROR: 11.94, 95%CI: 10.01–14.23), paroxetine (ROR: 11.39, 95%CI: 10.05–12.91), sertraline (ROR: 13.34, 95%CI: 11.86–15.01), fluvoxamine (ROR: 9.64, 95%CI: 5.01–18.56), citalopram (ROR: 15.09, 95%CI: 12.98–17.54), and escitalopram (ROR: 16.42, 95%CI: 14.11–19.12)].</div></div><div><h3>Conclusion</h3><div>This FAERS analysis detected significant disproportionality signals for male sexual dysfunction across SSRIs. Signal variation reflects reporting differences, not comparative risk, due to database limitations. These findings highlight the need for clinical vigilance and further investigation.</div></div>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":"402 ","pages":"Article 121336"},"PeriodicalIF":4.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146149849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2026-01-30DOI: 10.1016/j.jad.2026.121308
Paolo Olgiati , Maria Luca , Antonina Luca , Antonino Messina , Daniel Souery , Siegfried Kasper , Joseph Zohar , Stuart Montgomery , Panagiotis Ferentinos , Dan Rujescu , Raffaella Zanardi , Raffaele Ferri , Julien Mendlewicz , Alessandro Serretti
Background/objectives
Social anxiety disorder (SAD) frequently co-occurs with major depressive disorder (MDD). We examined the prevalence and clinical correlates of SAD across three heterogeneous MDD cohorts.
Methods
Secondary analyses were conducted in adult (CO-MED: n = 482; GSRD: n = 1398) and late-life (IRL-GREY: n = 438) patients. SAD was assessed dimensionally (PDSQ) and categorically (MINI; SCID-1). Cohort-specific instruments were used to assess depressive severity (QIDS; MADRS), suicidality (CHRT; MADRS; SIS) and hypomanic symptoms (ASRM; YMRS). In late-life depression, neurocognitive tests were administered. Multivariate models were adjusted for depression and anxiety levels.
Results
SAD prevalence varied markedly by samples and diagnostic definitions (CO-MED: 46.7% with PDSQ≥6; 17.0% with PDSQ>12; GSRD: 3.0%; IRL-GREY: 8.7%). Across cohorts, SAD was associated with earlier MDD onset (CO-MED: p < 0.001 d = −0.36; GSRD: p = 0.014 d = −0.39; IRL-GREY: p = 0.002 d = −0.54) and greater anxiety comorbidity (CO-MED: GAD: p < 0.001 d = 1.24; panic: p < 0.001 d = 1.29; GSRD: GAD: p < 0.001; panic: p < 0.001; IRL-GREY: agoraphobia: p < 0.001). After controlling for depression and anxiety levels, SAD was linked to higher suicide risk in both adult cohorts (CO-MED: OR 1.04 (1.01–1.08); GSRD: OR 1.29 (1.04–1.64)) and to lower 6-week remission in CO-MED cohort (OR 0.51 (0.29–0.91)).
Conclusions
In MDD, SAD has consistent associations with earlier illness onset and anxiety burden, modest associations with suicidality and antidepressant outcomes, and reduced impact in late life.
背景/目的:社交焦虑障碍(SAD)常与重度抑郁障碍(MDD)共存。我们检查了三个异质性重度抑郁症队列中SAD的患病率和临床相关性。方法:对成年(CO-MED: n = 482;GSRD: n = 1398)和老年(IRL-GREY: n = 438)患者进行二次分析。对SAD进行维度评定(PDSQ)和分类评定(MINI; SCID-1)。使用特定队列的工具评估抑郁严重程度(QIDS; MADRS)、自杀倾向(CHRT; MADRS; SIS)和轻躁症状(ASRM; YMRS)。对老年抑郁症患者进行神经认知测试。根据抑郁和焦虑水平调整多变量模型。结果:不同样本和诊断定义的SAD患病率差异显著(CO-MED: PDSQ≥6者为46.7%;PDSQ≥12者为17.0%;GSRD: 3.0%; IRL-GREY: 8.7%)。在所有队列中,SAD与早期MDD发病相关(CO-MED: p )。结论:在MDD中,SAD与早期发病和焦虑负担一致,与自杀和抗抑郁结局有适度关联,对晚年的影响较小。
{"title":"Prognostic implications of social anxiety comorbidity in major depressive disorder. Evidence from three large samples with adult and older patients","authors":"Paolo Olgiati , Maria Luca , Antonina Luca , Antonino Messina , Daniel Souery , Siegfried Kasper , Joseph Zohar , Stuart Montgomery , Panagiotis Ferentinos , Dan Rujescu , Raffaella Zanardi , Raffaele Ferri , Julien Mendlewicz , Alessandro Serretti","doi":"10.1016/j.jad.2026.121308","DOIUrl":"10.1016/j.jad.2026.121308","url":null,"abstract":"<div><h3>Background/objectives</h3><div>Social anxiety disorder (SAD) frequently co-occurs with major depressive disorder (MDD). We examined the prevalence and clinical correlates of SAD across three heterogeneous MDD cohorts.</div></div><div><h3>Methods</h3><div>Secondary analyses were conducted in adult (CO-MED: <em>n</em> = 482; GSRD: <em>n</em> = 1398) and late-life (IRL-GREY: <em>n</em> = 438) patients. SAD was assessed dimensionally (PDSQ) and categorically (MINI; SCID-1). Cohort-specific instruments were used to assess depressive severity (QIDS; MADRS), suicidality (CHRT; MADRS; SIS) and hypomanic symptoms (ASRM; YMRS). In late-life depression, neurocognitive tests were administered. Multivariate models were adjusted for depression and anxiety levels.</div></div><div><h3>Results</h3><div>SAD prevalence varied markedly by samples and diagnostic definitions (CO-MED: 46.7% with PDSQ≥6; 17.0% with PDSQ>12; GSRD: 3.0%; IRL-GREY: 8.7%). Across cohorts, SAD was associated with earlier MDD onset (CO-MED: <em>p</em> < 0.001 d = −0.36; GSRD: <em>p</em> = 0.014 d = −0.39; IRL-GREY: <em>p</em> = 0.002 d = −0.54) and greater anxiety comorbidity (CO-MED: GAD: <em>p</em> < 0.001 d = 1.24; panic: <em>p</em> < 0.001 d = 1.29; GSRD: GAD: <em>p</em> < 0.001; panic: <em>p</em> < 0.001; IRL-GREY: agoraphobia: <em>p</em> < 0.001). After controlling for depression and anxiety levels, SAD was linked to higher suicide risk in both adult cohorts (CO-MED: OR 1.04 (1.01–1.08); GSRD: OR 1.29 (1.04–1.64)) and to lower 6-week remission in CO-MED cohort (OR 0.51 (0.29–0.91)).</div></div><div><h3>Conclusions</h3><div>In MDD, SAD has consistent associations with earlier illness onset and anxiety burden, modest associations with suicidality and antidepressant outcomes, and reduced impact in late life.</div></div>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":"402 ","pages":"Article 121308"},"PeriodicalIF":4.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146099770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2026-01-31DOI: 10.1016/j.jad.2026.121274
Travis C. Evans , Kristen K. Ellard , Tracy Barbour , Sofia Uribe , Alexis Worthley , Audreyana Jagger-Rickels , Joshua Roffman , Joan A. Camprodon
Mood disorders such as major depressive disorder (MDD) and bipolar disorder (BD) are characterized by core approach and avoidance (AA) motivational system dysfunction. However, patterns of AA motivation dysfunction in mood disorders are markedly heterogeneous across studies, which is inconsistent with a singular pattern of AA motivation dysfunction in mood disorders. Thus, we utilized hierarchical cluster analysis (HCA) to classify multiple, distinct AA motivational profiles in both healthy control samples (Study 1: n = 427 and n = 462) and patients with MDD or BD (Study 2: n = 111). In both healthy control and clinical samples, we identified and replicated three distinct AA motivational profiles that were generally characterized as: 1). High Approach + Moderate Avoid, 2). Low Approach + Low Avoid, or 3). Low Approach + High Avoid. In both studies, AA motivational profiles were further characterized by multivariate, non-linear differences in self-reported reward and threat sensitivity. Compared to healthy controls, patients with mood disorders exhibited AA motivation dysfunction that systematically varied in severity across AA motivational profiles. Together, these results suggest that mood disorders may be more accurately characterized by multiple, distinct patterns of AA motivational dysfunction, which may ultimately be useful towards informing precision-medicine frameworks.
{"title":"Hierarchical cluster analysis reveals replicable trait approach-avoidance motivation profiles and heterogeneous dysfunction in mood disorders","authors":"Travis C. Evans , Kristen K. Ellard , Tracy Barbour , Sofia Uribe , Alexis Worthley , Audreyana Jagger-Rickels , Joshua Roffman , Joan A. Camprodon","doi":"10.1016/j.jad.2026.121274","DOIUrl":"10.1016/j.jad.2026.121274","url":null,"abstract":"<div><div>Mood disorders such as major depressive disorder (MDD) and bipolar disorder (BD) are characterized by core approach and avoidance (AA) motivational system dysfunction. However, patterns of AA motivation dysfunction in mood disorders are markedly heterogeneous across studies, which is inconsistent with a singular pattern of AA motivation dysfunction in mood disorders. Thus, we utilized hierarchical cluster analysis (HCA) to classify multiple, distinct AA motivational profiles in both healthy control samples (Study 1: <em>n</em> = 427 and <em>n</em> = 462) and patients with MDD or BD (Study 2: <em>n</em> = 111). In both healthy control and clinical samples, we identified and replicated three distinct AA motivational profiles that were generally characterized as: 1). High Approach + Moderate Avoid, 2). Low Approach + Low Avoid, or 3). Low Approach + High Avoid. In both studies, AA motivational profiles were further characterized by multivariate, non-linear differences in self-reported reward and threat sensitivity. Compared to healthy controls, patients with mood disorders exhibited AA motivation dysfunction that systematically varied in severity across AA motivational profiles. Together, these results suggest that mood disorders may be more accurately characterized by multiple, distinct patterns of AA motivational dysfunction, which may ultimately be useful towards informing precision-medicine frameworks.</div></div>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":"402 ","pages":"Article 121274"},"PeriodicalIF":4.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146105592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2026-02-04DOI: 10.1016/j.jad.2026.121337
Glenn Chuan Seng Foo , Minjae Choi , Shamsul Azhar Shah , Nurashikin Ibrahim , Noor Raihan Khamal , Shu-Sen Chang , Lai Fong Chan
Background
Limited research examined changes in suicide trends during COVID-19 outbreaks and related factors in lower-middle-income countries. We investigated the impact of the COVID-19 pandemic on suicide across different outbreak periods by sex, age, region, ethnicity, and method of suicide, and assessed potential factors associated with suicide rates in Malaysia.
Methods
Suicide data for Malaysia (January 2016–December 2022) were extracted from the Integrated Police Reporting System. Changes in monthly suicide rates across different COVID-19 outbreak periods and subgroups were examined using interrupted time series (ITS) analyses. We also examined the associations of suicide rates with indicators of economic performance (unemployment rate), outbreak control (Google mobility and Stringency Index of outbreak control measures), and outbreak severity (COVID-19 incidence and mortality).
Results
A marked increase in suicides above the expected number, based on past trends, was observed during the 3rd (October 2020–May 2021) and 4th (June 2021–December 2021) outbreaks, as well as the post-outbreak period (January–December 2022). These increases were found across nearly all sex, age, ethnicity, region, and suicide method groups. By contrast, no changes or lower-than-expected suicide rates were found in the early pandemic periods (January–September 2020). Higher suicide rates were associated with higher unemployment rates, higher stringency levels of outbreak control measures, and increased outbreak severity during the pandemic period.
Conclusion
Malaysian suicide rates increased above expectations in the later and post-outbreak periods and were associated with unemployment, outbreak control measures, and outbreak severity during the COVID-19 pandemic. These increases underscore the importance of continuous monitoring and prompt responses.
{"title":"Changes in suicide rates in Malaysia during the COVID-19 pandemic: An interrupted time series analysis","authors":"Glenn Chuan Seng Foo , Minjae Choi , Shamsul Azhar Shah , Nurashikin Ibrahim , Noor Raihan Khamal , Shu-Sen Chang , Lai Fong Chan","doi":"10.1016/j.jad.2026.121337","DOIUrl":"10.1016/j.jad.2026.121337","url":null,"abstract":"<div><h3>Background</h3><div>Limited research examined changes in suicide trends during COVID-19 outbreaks and related factors in lower-middle-income countries. We investigated the impact of the COVID-19 pandemic on suicide across different outbreak periods by sex, age, region, ethnicity, and method of suicide, and assessed potential factors associated with suicide rates in Malaysia.</div></div><div><h3>Methods</h3><div>Suicide data for Malaysia (January 2016–December 2022) were extracted from the Integrated Police Reporting System. Changes in monthly suicide rates across different COVID-19 outbreak periods and subgroups were examined using interrupted time series (ITS) analyses. We also examined the associations of suicide rates with indicators of economic performance (unemployment rate), outbreak control (Google mobility and Stringency Index of outbreak control measures), and outbreak severity (COVID-19 incidence and mortality).</div></div><div><h3>Results</h3><div>A marked increase in suicides above the expected number, based on past trends, was observed during the 3rd (October 2020–May 2021) and 4th (June 2021–December 2021) outbreaks, as well as the post-outbreak period (January–December 2022). These increases were found across nearly all sex, age, ethnicity, region, and suicide method groups. By contrast, no changes or lower-than-expected suicide rates were found in the early pandemic periods (January–September 2020). Higher suicide rates were associated with higher unemployment rates, higher stringency levels of outbreak control measures, and increased outbreak severity during the pandemic period.</div></div><div><h3>Conclusion</h3><div>Malaysian suicide rates increased above expectations in the later and post-outbreak periods and were associated with unemployment, outbreak control measures, and outbreak severity during the COVID-19 pandemic. These increases underscore the importance of continuous monitoring and prompt responses.</div></div>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":"402 ","pages":"Article 121337"},"PeriodicalIF":4.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146131949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2026-02-07DOI: 10.1016/j.jad.2026.121352
Olivia M. Losiewicz , Alainna Wen , Zachary D. Cohen , Samir Akre , Alex A.T. Bui , Michelle G. Craske
Emotional flexibility, thought to reflect the ability to adapt to internal and external environmental stimuli, is associated with psychological well-being. Emotional inertia and network density, defined as stability and interconnectedness, respectively, of emotions, are aspects of emotion dynamics that represent low emotional flexibility. Studies examining biological substrates of emotional persistence are largely limited to emotional inertia and non-depressed samples. Heart-rate variability (HRV) is a transdiagnostic biomarker for psychopathology thought to be associated with emotional flexibility. This study examined whether emotional inertia and network density were associated with HRV in adults with moderate-to-severe depression (N = 315). Participants completed three 8-day epochs of ecological momentary assessment (EMA) five times daily. Smartwatches measured HRV throughout the study. Emotional inertia and idiographic networks were calculated separately for EMA-rated negative and positive affect. Bayesian dynamic structural equation models with noninformative prior distributions examined the association between emotional inertia and HRV; hierarchical linear modeling examined associations between network density and HRV. Both daytime and bedrest HRV were inversely associated with contemporaneous network density of negative emotions. HRV was not associated with inertia, positive network density, or average EMA-reported affect, though it was associated with age, antidepressant medication, and physical exercise. This was the first study to examine HRV in relation to these emotion dynamics in a depressed sample. The results suggest that experiencing a variety of negative emotions within a short period of time may be associated with underlying biological inflexibility. Future studies should examine the directionality and mechanisms behind this effect and explore potential clinical interventions.
{"title":"Negative emotional inflexibility underlies biological inflexibility: An ecological momentary assessment and passive digital sensing study","authors":"Olivia M. Losiewicz , Alainna Wen , Zachary D. Cohen , Samir Akre , Alex A.T. Bui , Michelle G. Craske","doi":"10.1016/j.jad.2026.121352","DOIUrl":"10.1016/j.jad.2026.121352","url":null,"abstract":"<div><div>Emotional flexibility, thought to reflect the ability to adapt to internal and external environmental stimuli, is associated with psychological well-being. Emotional inertia and network density, defined as stability and interconnectedness, respectively, of emotions, are aspects of emotion dynamics that represent low emotional flexibility. Studies examining biological substrates of emotional persistence are largely limited to emotional inertia and non-depressed samples. Heart-rate variability (HRV) is a transdiagnostic biomarker for psychopathology thought to be associated with emotional flexibility. This study examined whether emotional inertia and network density were associated with HRV in adults with moderate-to-severe depression (<em>N</em> = 315). Participants completed three 8-day epochs of ecological momentary assessment (EMA) five times daily. Smartwatches measured HRV throughout the study. Emotional inertia and idiographic networks were calculated separately for EMA-rated negative and positive affect. Bayesian dynamic structural equation models with noninformative prior distributions examined the association between emotional inertia and HRV; hierarchical linear modeling examined associations between network density and HRV. Both daytime and bedrest HRV were inversely associated with contemporaneous network density of negative emotions. HRV was not associated with inertia, positive network density, or average EMA-reported affect, though it was associated with age, antidepressant medication, and physical exercise. This was the first study to examine HRV in relation to these emotion dynamics in a depressed sample. The results suggest that experiencing a variety of negative emotions within a short period of time may be associated with underlying biological inflexibility. Future studies should examine the directionality and mechanisms behind this effect and explore potential clinical interventions.</div></div>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":"402 ","pages":"Article 121352"},"PeriodicalIF":4.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146141968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2026-02-06DOI: 10.1016/j.jad.2026.121333
Tianyin Liu , Dara Kiu Yi Leung , Daniel Wong , Samson Tse , Paul Wong , Siu Man Ng , Wai Chi Chan , Vivian Lou , Jennifer Yee-Man Tang , Reynold Cheng , Shiyu Lu , Frankie Ho Chun Wong , Wen Zhang , Lesley Cai Yin Sze , Wai Wai Kwok , Martin Knapp , Terry Yat Sang Lum , Gloria Wong
Background
With population ageing and insufficient mental health workforce, there are huge treatment gaps for late-life depression. Real-world evidence of scalable preventive services is scarce. This study examines the effectiveness of an integrated selective and indicated prevention programme for late-life depression in a large group of older adults in Hong Kong.
Methods
This was a pragmatic quasi-experimental trial of a new service (“JoyAge”) for older people with risk factors for late-life depression or subsyndromal depressive symptoms. Participants were recruited and allocated, based on their district of residence, to receive JoyAge (N = 2975) or usual care (N = 441). The primary outcome was depressive symptoms (PHQ-9) at 12-month follow-up; secondary outcomes were anxiety symptoms (GAD-7) and loneliness (UCLA-3). Analyses were conducted in an intention-to-treat framework using mixed modelling, with subgroup analyses based on baseline depressive symptoms, and sensitivity analyses in a 1:1 (N = 422 each group) propensity score-matched sample.
Results
The JoyAge participants had a greater reduction in depressive symptoms over the 12-month period compared to those assigned to usual care (adjusted mean difference [AMD] = 1.65, 95% CI = 1.24–2.07, p < .001), similarly in anxiety symptoms (AMD = 1.47, 95% CI = 1.01–1.93, p < .001), and loneliness (AMD = 1.29, 95% CI = 0.98–1.60, p < .001). Results were similar in propensity-score matched analyses. Subgroup analysis showed that JoyAge was particularly effective among people with moderate to moderately severe symptoms and those with risk factors only.
Conclusions
Integrated late-life depression prevention can be effectively implemented at scale in rapidly ageing settings with a limited specialist mental health workforce. Economic analyses are needed to support further implementation.
{"title":"Effectiveness of an integrated prevention programme (“JoyAge”) for depressive symptoms, anxiety, and loneliness in older adults in Hong Kong: A pragmatic quasi-experimental trial","authors":"Tianyin Liu , Dara Kiu Yi Leung , Daniel Wong , Samson Tse , Paul Wong , Siu Man Ng , Wai Chi Chan , Vivian Lou , Jennifer Yee-Man Tang , Reynold Cheng , Shiyu Lu , Frankie Ho Chun Wong , Wen Zhang , Lesley Cai Yin Sze , Wai Wai Kwok , Martin Knapp , Terry Yat Sang Lum , Gloria Wong","doi":"10.1016/j.jad.2026.121333","DOIUrl":"10.1016/j.jad.2026.121333","url":null,"abstract":"<div><h3>Background</h3><div>With population ageing and insufficient mental health workforce, there are huge treatment gaps for late-life depression. Real-world evidence of scalable preventive services is scarce. This study examines the effectiveness of an integrated selective and indicated prevention programme for late-life depression in a large group of older adults in Hong Kong.</div></div><div><h3>Methods</h3><div>This was a pragmatic quasi-experimental trial of a new service (“JoyAge”) for older people with risk factors for late-life depression or subsyndromal depressive symptoms. Participants were recruited and allocated, based on their district of residence, to receive JoyAge (<em>N</em> = 2975) or usual care (<em>N</em> = 441). The primary outcome was depressive symptoms (PHQ-9) at 12-month follow-up; secondary outcomes were anxiety symptoms (GAD-7) and loneliness (UCLA-3). Analyses were conducted in an intention-to-treat framework using mixed modelling, with subgroup analyses based on baseline depressive symptoms, and sensitivity analyses in a 1:1 (<em>N</em> = 422 each group) propensity score-matched sample.</div></div><div><h3>Results</h3><div>The JoyAge participants had a greater reduction in depressive symptoms over the 12-month period compared to those assigned to usual care (adjusted mean difference [AMD] = 1.65, 95% CI = 1.24–2.07, <em>p</em> < .001), similarly in anxiety symptoms (AMD = 1.47, 95% CI = 1.01–1.93, <em>p</em> < .001), and loneliness (AMD = 1.29, 95% CI = 0.98–1.60, <em>p</em> < .001). Results were similar in propensity-score matched analyses. Subgroup analysis showed that JoyAge was particularly effective among people with moderate to moderately severe symptoms and those with risk factors only.</div></div><div><h3>Conclusions</h3><div>Integrated late-life depression prevention can be effectively implemented at scale in rapidly ageing settings with a limited specialist mental health workforce. Economic analyses are needed to support further implementation.</div></div>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":"402 ","pages":"Article 121333"},"PeriodicalIF":4.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2026-02-06DOI: 10.1016/j.jad.2026.121341
Sarah Bloch-Elkouby , Rawad El-Hayek , Lisa Cohen , Jimmy Pengyu Chen , Bernard Gorman , Yael Apter , Erin Wheeler , Byounyoung Park , Anna Stefania Prekas , Igor Galynker
Background
The Suicide Crisis Syndrome (SCS) is a suicidal mental state and a proposed DSM diagnostic condition shown to predict short-term suicidal behaviors among clinical and non-clinical populations in the United States and worldwide. The goal of this study was to develop and assess the psychometric properties of a short clinician-rated SCS diagnostic tool, the SCS Checklist (SCS-C), to provide a structured assessment of patients' SCS through clinical interview.
Method
The SCS-C, a clinician-rated measure composed of 15 binary (yes/no) items was developed and administered to 219 patients upon admission into an inpatient psychiatric unit. Factor structure, internal and interrater reliability, concurrent construct validity (i.e., convergent and divergent validity), and concurrent criterion validity (within one week prior to inpatient admission) were respectively assessed using Confirmatory Factor Analysis, Cronbach's Alpha and McDonald's Omega, Cohen's Kappa, and linear and logistic regressions.
Results
The SCS-C demonstrated excellent fit for a one factor solution, high internal consistency (Cronbach's α = 0.87; McDonalds' Ω = 0.89), moderate convergent validity, good divergent validity, as well as good concurrent criterion validity with regards to suicidal behaviors.
Discussion
This study's findings suggest that the SCS-C is a psychometrically valid and reliable diagnostic tool to assess the presence of the SCS through a swift clinical interview, regardless of patients' disclosure of suicidal ideation. Given the persistent difficulty in evaluating suicide risk through patient self-report, this concise diagnostic tool holds substantial clinical promise for improving suicide risk detection and prevention. Future studies will need to investigate the predictive validity of the instrument.
{"title":"The clinician rated suicide crisis syndrome checklist (SCS-C): Structure, reliability, and concurrent validity among adult psychiatric inpatients","authors":"Sarah Bloch-Elkouby , Rawad El-Hayek , Lisa Cohen , Jimmy Pengyu Chen , Bernard Gorman , Yael Apter , Erin Wheeler , Byounyoung Park , Anna Stefania Prekas , Igor Galynker","doi":"10.1016/j.jad.2026.121341","DOIUrl":"10.1016/j.jad.2026.121341","url":null,"abstract":"<div><h3>Background</h3><div>The Suicide Crisis Syndrome (SCS) is a suicidal mental state and a proposed DSM diagnostic condition shown to predict short-term suicidal behaviors among clinical and non-clinical populations in the United States and worldwide. The goal of this study was to develop and assess the psychometric properties of a short clinician-rated SCS diagnostic tool, the SCS Checklist (SCS-C), to provide a structured assessment of patients' SCS through clinical interview.</div></div><div><h3>Method</h3><div>The SCS-C, a clinician-rated measure composed of 15 binary (yes/no) items was developed and administered to 219 patients upon admission into an inpatient psychiatric unit. Factor structure, internal and interrater reliability, concurrent construct validity (i.e., convergent and divergent validity), and concurrent criterion validity (within one week prior to inpatient admission) were respectively assessed using Confirmatory Factor Analysis, Cronbach's Alpha and McDonald's Omega, Cohen's Kappa, and linear and logistic regressions.</div></div><div><h3>Results</h3><div>The SCS-C demonstrated excellent fit for a one factor solution, high internal consistency (Cronbach's <em>α</em> = 0.87; McDonalds' <em>Ω</em> = 0.89), moderate convergent validity, good divergent validity, as well as good concurrent criterion validity with regards to suicidal behaviors.</div></div><div><h3>Discussion</h3><div>This study's findings suggest that the SCS-C is a psychometrically valid and reliable diagnostic tool to assess the presence of the SCS through a swift clinical interview, regardless of patients' disclosure of suicidal ideation. Given the persistent difficulty in evaluating suicide risk through patient self-report, this concise diagnostic tool holds substantial clinical promise for improving suicide risk detection and prevention. Future studies will need to investigate the predictive validity of the instrument.</div></div>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":"402 ","pages":"Article 121341"},"PeriodicalIF":4.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146141900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2026-01-26DOI: 10.1016/j.jad.2026.121284
Runming Liu , Gaomeng Luo , Xiaobing Wang , Ziyue Xu , Jiazhi Jiang , Peng Huang , Fei Zeng , Junhui Liu , Xiang Li , Sha Liu , Wei Wei
Background
Patients with ulcerative colitis (UC) exhibit an elevated risk for post-traumatic stress disorder (PTSD) and frequently demonstrate severe symptomatology, suggesting a gut–brain axis connection. UC-associated chronic inflammation and immune dysregulation can influence central nervous system function via neuroimmune signaling, potentially reshaping molecular and transcriptional programs within fear-related neural circuits. However, the molecular mechanisms underlying this clinical association remain poorly characterized.
Methods
We analyzed PTSD and UC microarray data from the Gene Expression Omnibus (GEO) following background correction and normalization. Disease-associated genes were identified through differentially expressed gene (DEG) analysis and weighted gene co-expression network analysis (WGCNA), followed by gene set enrichment analysis (GSEA), Gene Ontology (GO) enrichment, CIBERSORT immune profiling, and protein–protein interaction (PPI) analysis. Key targets were validated in intestinal tissue from a murine model of UC and blood samples from a murine model of PTSD. A combined UC–PTSD mouse model was established for behavioral validation; viral knockdown targeting the prelimbic cortex (PL) was employed to test candidate genes functionally.
Conclusion
We identified shared molecular pathways and core genes linking UC and PTSD. The comorbid model demonstrated that UC intensifies PTSD-like behaviors. Furthermore, Knockdown of Glrx in the PL alleviated fear retrieval following UC induction, establishing Glrx as a mechanistic node along the gut–brain axis in UC-associated PTSD vulnerability.
{"title":"Gut–brain axis biomarkers link intestinal inflammation to post-traumatic stress disorder vulnerability","authors":"Runming Liu , Gaomeng Luo , Xiaobing Wang , Ziyue Xu , Jiazhi Jiang , Peng Huang , Fei Zeng , Junhui Liu , Xiang Li , Sha Liu , Wei Wei","doi":"10.1016/j.jad.2026.121284","DOIUrl":"10.1016/j.jad.2026.121284","url":null,"abstract":"<div><h3>Background</h3><div>Patients with ulcerative colitis (UC) exhibit an elevated risk for post-traumatic stress disorder (PTSD) and frequently demonstrate severe symptomatology, suggesting a gut–brain axis connection. UC-associated chronic inflammation and immune dysregulation can influence central nervous system function via neuroimmune signaling, potentially reshaping molecular and transcriptional programs within fear-related neural circuits. However, the molecular mechanisms underlying this clinical association remain poorly characterized.</div></div><div><h3>Methods</h3><div>We analyzed PTSD and UC microarray data from the Gene Expression Omnibus (GEO) following background correction and normalization. Disease-associated genes were identified through differentially expressed gene (DEG) analysis and weighted gene co-expression network analysis (WGCNA), followed by gene set enrichment analysis (GSEA), Gene Ontology (GO) enrichment, CIBERSORT immune profiling, and protein–protein interaction (PPI) analysis. Key targets were validated in intestinal tissue from a murine model of UC and blood samples from a murine model of PTSD. A combined UC–PTSD mouse model was established for behavioral validation; viral knockdown targeting the prelimbic cortex (PL) was employed to test candidate genes functionally.</div></div><div><h3>Conclusion</h3><div>We identified shared molecular pathways and core genes linking UC and PTSD. The comorbid model demonstrated that UC intensifies PTSD-like behaviors. Furthermore, Knockdown of Glrx in the PL alleviated fear retrieval following UC induction, establishing Glrx as a mechanistic node along the gut–brain axis in UC-associated PTSD vulnerability.</div></div>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":"402 ","pages":"Article 121284"},"PeriodicalIF":4.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146122614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2026-02-05DOI: 10.1016/j.jad.2026.121351
Martin Plöderl , Florian Naudet
{"title":"Recommendations for repeated dosings of ketamine/esketamine rest on an uncertain evidence base. Response to Le et al., 2025","authors":"Martin Plöderl , Florian Naudet","doi":"10.1016/j.jad.2026.121351","DOIUrl":"10.1016/j.jad.2026.121351","url":null,"abstract":"","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":"402 ","pages":"Article 121351"},"PeriodicalIF":4.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146131635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-06-01Epub Date: 2026-02-05DOI: 10.1016/j.jad.2026.121353
Jun Zhou , Aijun Liao , Xiaoqian Ma , Zihao Yang , Chunwang Li , Ying He , Xiaogang Chen
Background
Cognitive dysfunction is a prevalent symptom in patients with bipolar II disorder (BD-II) depression, yet its underlying neural mechanisms remain insufficiently understood. This study aimed to investigate the relationship between local spontaneous neural activity and cognitive dysfunction in BD-II depression using the Regional Homogeneity (ReHo) method.
Methods
A total of 77 first-episode drug-naïve patients with BD-II depression and 69 healthy controls (HC) underwent magnetic resonance imaging (MRI) scans. Cognitive function was assessed using the Hopkins Verbal Learning Test-Revised (HVLT-R), Stroop Color and Word Test (SCWT), Verbal Fluency Test (VFT), and Wisconsin Card Sorting Test (WCST).
Results
Patients with BD-II depression exhibited widespread cognitive impairments across multiple domains, including verbal learning and memory, reaction time, executive function, working memory, semantic retrieval, and cognitive flexibility. Moreover, significant alterations in ReHo values were observed in several key brain regions, such as the precentral and postcentral gyri, precuneus, medial frontal gyrus (MFG), triangular part of inferior frontal gyrus, and Rolandic operculum. Notably, after Bonferroni correction, ReHo values in the right MFG were significantly correlated with both immediate and delayed recall scores on the HVLT-R (all P < 0.0002), suggesting a crucial role of this region in cognitive processes.
Conclusion
These findings indicate that abnormal neural activity in specific brain regions may serve as potential neurobiological markers of cognitive dysfunction in BD-II depression. Identifying these neural correlates could contribute to a better understanding of the pathophysiology of BD-II and inform the development of targeted therapeutic strategies.
{"title":"Relationship between regional homogeneity changes and cognitive dysfunction in patients with first-episode drug-naïve bipolar II disorder in the depressive phase","authors":"Jun Zhou , Aijun Liao , Xiaoqian Ma , Zihao Yang , Chunwang Li , Ying He , Xiaogang Chen","doi":"10.1016/j.jad.2026.121353","DOIUrl":"10.1016/j.jad.2026.121353","url":null,"abstract":"<div><h3>Background</h3><div>Cognitive dysfunction is a prevalent symptom in patients with bipolar II disorder (BD-II) depression, yet its underlying neural mechanisms remain insufficiently understood. This study aimed to investigate the relationship between local spontaneous neural activity and cognitive dysfunction in BD-II depression using the Regional Homogeneity (ReHo) method.</div></div><div><h3>Methods</h3><div>A total of 77 first-episode drug-naïve patients with BD-II depression and 69 healthy controls (HC) underwent magnetic resonance imaging (MRI) scans. Cognitive function was assessed using the Hopkins Verbal Learning Test-Revised (HVLT-R), Stroop Color and Word Test (SCWT), Verbal Fluency Test (VFT), and Wisconsin Card Sorting Test (WCST).</div></div><div><h3>Results</h3><div>Patients with BD-II depression exhibited widespread cognitive impairments across multiple domains, including verbal learning and memory, reaction time, executive function, working memory, semantic retrieval, and cognitive flexibility. Moreover, significant alterations in ReHo values were observed in several key brain regions, such as the precentral and postcentral gyri, precuneus, medial frontal gyrus (MFG), triangular part of inferior frontal gyrus, and Rolandic operculum. Notably, after Bonferroni correction, ReHo values in the right MFG were significantly correlated with both immediate and delayed recall scores on the HVLT-R (all <em>P</em> < 0.0002), suggesting a crucial role of this region in cognitive processes.</div></div><div><h3>Conclusion</h3><div>These findings indicate that abnormal neural activity in specific brain regions may serve as potential neurobiological markers of cognitive dysfunction in BD-II depression. Identifying these neural correlates could contribute to a better understanding of the pathophysiology of BD-II and inform the development of targeted therapeutic strategies.</div></div>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":"402 ","pages":"Article 121353"},"PeriodicalIF":4.9,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146137593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}